Fluoxetine treatment of rat neonates significantly reduces oxidative stress in the hippocampus and in behavioral indicators of anxiety later in postnatal life

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 4, 2014, Pages 330-337

  da Silva, Aline Isabel ^a   Galindo, Ligia Cristina Monteiro ^a   Nascimento, Luciana ^a   Freitas, Cristiane Moura ^a   Manhaes de Castro, Raul ^a   Lagranha, Claudia Jacques ^a   de Souza, Sandra Lopes ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Anxiety; Fluoxetine; Oxidative stress; Serotonin

Indexed keywords

CATALASE; FLUOXETINE; GLUTATHIONE TRANSFERASE; SELFEMRA; SEROTONIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BRAIN DEVELOPMENT; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOOD INTAKE; HIPPOCAMPUS; LIPID PEROXIDATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SATIETY; TRANQUILIZING ACTIVITY;

ANIMALS; ANIMALS, NEWBORN; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BODY WEIGHT; EATING; FLUOXETINE; HIPPOCAMPUS; HYPOTHALAMUS; LIPID METABOLISM; OXIDATIVE STRESS; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 84898737436     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0321     Document Type: Article

References (51)

1. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105: 121-126. doi:10.1016/S00766879(84)05016-3. PMID:6727660.
2. Ansorge, M.S., Zhou, M., Lira, A., Hen, R., and Gingrich, J.A. 2004. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science, 306: 879-881. doi:10.1126/science.1101678. PMID:15514160.
3. Antin, J., Gibbs, J., Holt, J., Young, R.C., and Smith, G.P. 1975. Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J. Comp. Physiol. Psychol. 89: 784-790. doi:10.1037/h0077040. PMID:1176672.
4. Baldwin, D., Woods, R., Lawson, R., and Taylor, D. 2011. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ, 342: d1199. doi:10.1136/bmj.d1199. PMID:21398351.
5. Benani, A., Troy, S., Carmona, M.C., Fioramonti, X., Lorsignol, A., Leloup, C., et al. 2007. Role for mitochondrial reactive oxygen species in brain lipid sensing: redox regulation of food intake. Diabetes, 56: 152-160. doi:10.2337/db060440. PMID:17192477.
6. Berry, A., Capone, F., Giorgio, M., Pelicci, P.G., de Kloet, E.R., Alleva, E., et al. 2007. Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice. Exp. Gerontol. 42: 37-45. doi:10.1016/j.exger.2006.05.018. PMID:16809014.
7. Blundell, J.E. 1984. Serotonin and appetite. Neuropharmacology, 23: 1537-1551. doi:10.1016/0028-3908(84)90098-4. PMID:6152027.
8. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254. doi:10.1016/0003-2697(76)90527-3. PMID:942051.
9. CCAC (Canadian Council on Animal Care in science). 1993. Guide to the care and use of experimental animals. CCAC, Ottawa, Ont.
10. Chung, Y.C., Kim, S.R., and Jin, B.K. 2010. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J. Immunol. 185: 1230-1237. doi:10.4049/jimmunol.1000208. PMID:20566832.
11. Crupi, R., Marino, A., and Cuzzocrea, S. 2011. New therapeutic strategy for mood disorders. Curr. Med. Chem. 18: 4284-4298. doi:10.2174/092986711797200417. PMID:21861822.
12. Davanzo, R., Copertino, M., De Cunto, A., Minen, F., and Amaddeo, A. 2011. Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed. Med. 6: 89-98. doi:10.1089/bfm.2010.0019. PMID:20958101.
13. de Oliveira, M.R., Silvestrin, R.B., Mello, E.S.T., and Moreira, J.C. 2007. Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses. Neurotoxicology, 28: 1191-1199. doi:10.1016/j.neuro.2007.07.008. PMID:17727954.
14. Diano, S., Liu, Z.W., Jeong, J.K., Dietrich, M.O., Ruan, H.B., Kim, E., et al. 2011. Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat. Med. 17: 1121-1127. doi:10.1038/nm.2421. PMID:21873987.
15. Draper, H.H., Squires, E.J., Mahmoodi, H., Wu, J., Agarwal, S., and Hadley, M. 1993. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic. Biol. Med. 15: 353-363. doi:10.1016/0891-5849(93)90035-S. PMID:8225017.
16. Drapier, D., Bentue-Ferrer, D., Laviolle, B., Millet, B., Allain, H., Bourin, M., and Reymann, J.M. 2007. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav. Brain Res. 176: 202-209. doi:10.1016/j.bbr.2006.10.002. PMID:17095104.
17. El-Ansary, A., Al-Daihan, S., Al-Dbass, A., and Al-Ayadhi, L. 2010. Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. Clin. Biochem. 43: 63-70. doi:10.1016/j.clinbiochem.2009. 09.008. PMID:19781542.
18. Francis-Oliveira, J., Ponte, B., Barbosa, A.P., Verissimo, L.F., Gomes, M.V., Pelosi, G.G., et al. 2013. Fluoxetine exposure during pregnancy and lactation: Effects on acute stress response and behavior in the novelty-suppressed feeding are age and gender-dependent in rats. Behav. Brain Res. 252: 195-203. doi:10.1016/j.bbr.2013.05.064. PMID:23764459.
19. Gigante, A.D., Young, L.T., Yatham, L.N., Andreazza, A.C., Nery, F.G., Grinberg, L.T., et al. 2011. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int. J. Neuropsychopharmacol. 14: 1075-1089. doi:10.1017/S146114571000146X. PMID: 21205433.
20. Green, A.R. 1984. 5-HT-mediated behavior. Animal studies. Neuropharmacology, 23: 1521-1528. doi:10.1016/0028-3908(84)90096-0. PMID:6152026.
21. Habig, W.H., Pabst, M.J., and Jakoby, W.B. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249: 7130-7139. PMID:4436300.
22. Halliwell, B. 2006. Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97: 1634-1658. doi:10.1111/j.1471-4159.2006.03907.x. PMID:16805774.
23. Hovatta, I., Tennant, R.S., Helton, R., Marr, R.A., Singer, O., Redwine, J.M., et al. 2005. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature, 438: 662-666. doi:10.1038/nature04250. PMID:16244648.
24. Iversen, S.D. 1984. 5-HT and anxiety. Neuropharmacology, 23: 1553-1560. doi:10. 1016/0028-3908(84)90099-6. PMID:6152028.
25. Krishnan, V., and Nestler, E.J. 2008. The molecular neurobiology of depression. Nature, 455: 894-902. doi:10.1038/nature07455. PMID:18923511.
26. Leloup, C., Magnan, C., Benani, A., Bonnet, E., Alquier, T., Offer, G., et al. 2006. Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing. Diabetes, 55: 2084-2090. doi:10.2337/db06-0086. PMID:16804079.
27. Lister, R.G. 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.), 92: 180-185. doi:10.1007/BF00177912. PMID:3110839.
28. Masood, A., Nadeem, A., Mustafa, S.J., and O'Donnell, J.M. 2008. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J. Pharmacol. Exp. Ther. 326: 369-379. doi:10.1124/jpet.108.137208. PMID:18456873.
29. Mendes-da-Silva, C., de Souza, S.L., Barreto-Medeiros, J.M., de Freitas-Silva, S.R., Antunes, D.E., Cunha, A.D., et al. 2002. Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swim in adult rats. Arq. Neuropsiquiatr. 60: 928-931. doi:10.1590/S0004-282X2002000600008. PMID: 12563382.
30. Misra, H.P., and Fridovich, I. 1972. The generation of superoxide radical during the autoxidation of hemoglobin. J. Biol. Chem. 247: 6960-6962. PMID: 4673289.
31. Moretti, M., Colla, A., de Oliveira Balen, G., Dos Santos, D.B., Budni, J., de Freitas, A.E., et al. 2012. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J. Psychiatr. Res. 46: 331-340. doi:10.1016/j. jpsychires.2011.11.009. PMID:22154133.
32. Navarro, A., and Boveris, A. 2007. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292: C670-C686. doi:10.1152/ajpcell.00213.2006. PMID:17020935.
33. NIH (National Institutes for Health US). 2011. Guide for the care and use of laboratory animals, 8th Ed. National Academy Press, Washington, D.C. [Available from e-linkurlwww.nap.edu/catalog.phprecord-id12910/url/e-link.
34. Novio, S., Nunez, M.J., Amigo, G., and Freire-Garabal, M. 2011. Effects of fluoxetine on the oxidative status of peripheral blood leucocytes of restraintstressed mice. Basic Clin. Pharmacol. Toxicol. 109: 365-371. doi:10.1111/j.17427843.2011.00736.x. PMID:21624059.
35. Nulman, I., Rovet, J., Stewart, D.E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., and Koren, G. 2002. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am. J. Psychiatry, 159: 1889-1895. doi:10.1176/appi.ajp.159.11.1889. PMID:12411224.
36. Oberlander, T.F., Gingrich, J.A., and Ansorge, M.S. 2009. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin. Pharmacol. Ther. 86: 672-677. doi:10.1038/clpt. 2009.201. PMID:19890255.
37. Oliveira Ldos, S., da Silva, L.P., da Silva, A.I., Magalhaes, C.P., de Souza, S.L., and de Castro, R.M. 2011. Effects of early weaning on the circadian rhythm and behavioral satiety sequence in rats. Behav. Processes, 86: 119-124. doi:10.1016/j.beproc.2010.10.001. PMID:20974233.
38. Olivier, J.D., Blom, T., Arentsen, T., and Homberg, J.R. 2011a. The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review. Prog. Neuropsychopharmacol. Biol. Psychiatry, 35: 1400-1408. doi:10. 1016/j.pnpbp.2010.09.013. PMID:20883714.
39. Olivier, J.D., Valles, A., van Heesch, F., Afrasiab-Middelman, A., Roelofs, J.J., Jonkers, M., Peeters, E.J., et al. 2011b. Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berl.), 217: 419-432. doi:10.1007/s00213-011-2299-z. PMID:21487650.
40. Orozco-Solis, R., Lopes de Souza, S., Barbosa Matos, R.J., Grit, I., Le Bloch, J., Nguyen, P., et al. 2009. Perinatal undernutrition-induced obesity is independent of the developmental programming of feeding. Physiol. Behav. 96: 481-492. doi:10.1016/j.physbeh.2008.11.016. PMID:19100759.
41. Pawluski, J.L., Rayen, I., Niessen, N.A., Kristensen, S., van Donkelaar, E.L., Balthazart, J., et al. 2012. Developmental fluoxetine exposure differentially alters central and peripheral measures of the HPA system in adolescent male and female offspring. Neuroscience, 220: 131-141. doi:10.1016/j.neuroscience. 2012.06.034. PMID:22728102.
42. Shen, Y.B., Voilque, G., Kim, J.D., Odle, J., and Kim, S.W. 2012. Effects of elevating tryptophan intake on growth and physiological changes in nursery pigs. J. Anim. Sci. 90: 2264-2275. doi:10.2527/jas.2011-4203. PMID:22287672.
43. Silva, C.M., Goncalves, L., Manhaes-de-Castro, R., and Nogueira, M.I. 2010. Postnatal fluoxetine treatment affects the development of serotonergic neurons in rats. Neurosci. Lett. 483: 179-183. doi:10.1016/j.neulet.2010.08.003. PMID: 20696211.
44. Simansky, K.J., and Vaidya, A.H. 1990. Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists. Brain Res. Bull. 25: 953-960. doi:10.1016/0361-9230(90)90194-5. PMID:2149668.
45. Souza, C.G., Moreira, J.D., Siqueira, I.R., Pereira, A.G., Rieger, D.K., Souza, D.O., et al. 2007. Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci. 81: 198-203. doi:10.1016/j.lfs.2007.05.001. PMID:17574275.
46. Trouche, E., Mias, C., Seguelas, M.H., Ordener, C., Cussac, D., and Parini, A. 2010. Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis. Stem Cells Dev. 19: 1571-1578. doi:10.1089/scd.2009.0353. PMID:20073575.
47. Wellman, P.J., Jones, S.L., and Miller, D.K. 2003. Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat. Pharmacol. Biochem. Behav. 75: 103-114. doi:10.1016/S0091-3057(03)00045-5. PMID:12759118.
48. Wong, D.T., and Bymaster, F.P. 1995. Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors. Adv. Exp. Med. Biol. 363: 77-95. PMID:7618533.
49. Wong, D.T., Bymaster, F.P., and Engleman, E.A. 1995. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57: 411-441. doi:10.1016/0024-3205(95)00209-O. PMID:7623609.
50. Wrona, M.Z., and Dryhurst, G. 1998. Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders. Chem. Res. Toxicol. 11: 639-650. doi:10.1021/tx970185w. PMID:9625732.
51. Zafir, A., Ara, A., and Banu, N. 2009. Invivo antioxidant status: a putative target of antidepressant action. Prog. Neuropsychopharmacol. Biol. Psychiatry, 33: 220-228. doi:10.1016/j.pnpbp.2008.11.010. PMID:19059298.